What is the projected market valuation of the Radiopharmaceuticals Market by 2035?

The Radiopharmaceuticals Market is projected to reach a valuation of 18.52 USD Billion by 2035. Read More

What was the market valuation of the Radiopharmaceuticals Market in 2024?

In 2024, the Radiopharmaceuticals Market was valued at 7.09 USD Billion. Read More

What is the expected CAGR for the Radiopharmaceuticals Market during the forecast period 2025 - 2035?

The expected CAGR for the Radiopharmaceuticals Market during the forecast period 2025 - 2035 is 9.12%. Read More

Which companies are considered key players in the Radiopharmaceuticals Market?

Key players in the Radiopharmaceuticals Market include Cardinal Health, GE Healthcare, Bayer AG, Novartis AG, Siemens Healthineers, Elekta AB, Lantheus Medical Imaging, Bracco Imaging S.p.A., and NorthStar Medical Radioisotopes. Read More

What are the projected valuations for the Diagnostic and Therapeutic Radiopharmaceuticals segments by 2035?

By 2035, the Diagnostic Radiopharmaceuticals segment is projected to reach 7.36 USD Billion, while the Therapeutic Radiopharmaceuticals segment is expected to reach 11.16 USD Billion. Read More

How do the end-use segments of the Radiopharmaceuticals Market compare in 2024?

In 2024, the Hospitals segment was valued at 2.83 USD Billion, Diagnostic Imaging Centers at 2.12 USD Billion, and Research Institutions at 2.14 USD Billion. Read More

What is the anticipated growth for the Research segment of the Radiopharmaceuticals Market by 2035?

The Research segment is anticipated to grow to 3.8 USD Billion by 2035. Read More

What are the projected values for Radioisotopes and Radiolabeled Compounds by 2035?

By 2035, both Radioisotopes and Radiolabeled Compounds are projected to reach 7.36 USD Billion. Read More

What is the expected market trend for Diagnostic Imaging Centers in the Radiopharmaceuticals Market?

The Diagnostic Imaging Centers segment is expected to grow to 5.51 USD Billion by 2035. Read More

How does the Radiopharmaceuticals Market's growth compare to other healthcare sectors?

The Radiopharmaceuticals Market's growth, with a projected CAGR of 9.12%, indicates a robust expansion compared to many other healthcare sectors. Read More

Marché des radio-pharmaceutiques

ID: MRFR/HC/1119-CR

200 Pages

Nidhi Mandole

Last Updated: May 06, 2026

Rapport de recherche sur le marché des radiopharmaceutiques : taille, part, analyse des tendances par applications (diagnostic, thérapie, recherche), par types (radiopharmaceutiques diagnostiques, radiopharmaceutiques thérapeutiques), par classe de radiopharmaceutiques (radioisotopes, composés radiomarqués, générateurs de radiopharmaceutiques), par utilisation finale (hôpitaux, centres d'imagerie diagnostique, institutions de recherche) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie-Pacifique, Moyen-Orient et Afrique) - Perspectives de croissance et prévisions de l'industrie 2025 à 2035

Résumé Table des matières segmentation Méthodologie Télécharger le PDF

1 EXECUTIVE SUMMARY
1. 1.1 Market Overview
2. 1.2 Key Findings
3. 1.3 Market Segmentation
4. 1.4 Competitive Landscape
5. 1.5 Challenges and Opportunities
6. 1.6 Future Outlook
2 MARKET INTRODUCTION
1. 2.1 Definition
2. 2.2 Scope of the study
  1. 2.2.1 Research Objective
  2. 2.2.2 Assumption
  3. 2.2.3 Limitations
3 RESEARCH METHODOLOGY
1. 3.1 Overview
2. 3.2 Data Mining
3. 3.3 Secondary Research
4. 3.4 Primary Research
  1. 3.4.1 Primary Interviews and Information Gathering Process
  2. 3.4.2 Breakdown of Primary Respondents
5. 3.5 Forecasting Model
6. 3.6 Market Size Estimation
  1. 3.6.1 Bottom-Up Approach
  2. 3.6.2 Top-Down Approach
7. 3.7 Data Triangulation
8. 3.8 Validation
4 MARKET DYNAMICS
1. 4.1 Overview
2. 4.2 Drivers
3. 4.3 Restraints
4. 4.4 Opportunities
5 MARKET FACTOR ANALYSIS
1. 5.1 Value chain Analysis
2. 5.2 Porter's Five Forces Analysis
  1. 5.2.1 Bargaining Power of Suppliers
  2. 5.2.2 Bargaining Power of Buyers
  3. 5.2.3 Threat of New Entrants
  4. 5.2.4 Threat of Substitutes
  5. 5.2.5 Intensity of Rivalry
3. 5.3 COVID-19 Impact Analysis
  1. 5.3.1 Market Impact Analysis
  2. 5.3.2 Regional Impact
  3. 5.3.3 Opportunity and Threat Analysis
6 RADIOPHARMACEUTICALS MARKET, BY APPLICATION (USD BILLION)
1. 6.1 Diagnosis
2. 6.2 Therapy
3. 6.3 Research
7 RADIOPHARMACEUTICALS MARKET, BY TYPE (USD BILLION)
1. 7.1 Diagnostic Radiopharmaceuticals
2. 7.2 Therapeutic Radiopharmaceuticals
8 RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS (USD BILLION)
1. 8.1 Radioisotopes
2. 8.2 Radiolabeled Compounds
3. 8.3 Radiopharmaceutical Generators
9 RADIOPHARMACEUTICALS MARKET, BY END USE (USD BILLION)
1. 9.1 Hospitals
2. 9.2 Diagnostic Imaging Centers
3. 9.3 Research Institutions
10 RADIOPHARMACEUTICALS MARKET, BY REGIONAL (USD BILLION)
1. 10.1 North America
  1. 10.1.1 US
  2. 10.1.2 Canada
2. 10.2 Europe
  1. 10.2.1 Germany
  2. 10.2.2 UK
  3. 10.2.3 France
  4. 10.2.4 Russia
  5. 10.2.5 Italy
  6. 10.2.6 Spain
  7. 10.2.7 Rest of Europe
3. 10.3 APAC
  1. 10.3.1 China
  2. 10.3.2 India
  3. 10.3.3 Japan
  4. 10.3.4 South Korea
  5. 10.3.5 Malaysia
  6. 10.3.6 Thailand
  7. 10.3.7 Indonesia
  8. 10.3.8 Rest of APAC
4. 10.4 South America
  1. 10.4.1 Brazil
  2. 10.4.2 Mexico
  3. 10.4.3 Argentina
  4. 10.4.4 Rest of South America
5. 10.5 MEA
  1. 10.5.1 GCC Countries
  2. 10.5.2 South Africa
  3. 10.5.3 Rest of MEA
11 COMPETITIVE LANDSCAPE
1. 11.1 Overview
2. 11.2 Competitive Analysis
3. 11.3 Market share Analysis
4. 11.4 Major Growth Strategy in the Radiopharmaceuticals Market
5. 11.5 Competitive Benchmarking
6. 11.6 Leading Players in Terms of Number of Developments in the Radiopharmaceuticals Market
7. 11.7 Key developments and growth strategies
  1. 11.7.1 New Product Launch/Service Deployment
  2. 11.7.2 Merger & Acquisitions
  3. 11.7.3 Joint Ventures
8. 11.8 Major Players Financial Matrix
  1. 11.8.1 Sales and Operating Income
  2. 11.8.2 Major Players R&D Expenditure. 2023
12 COMPANY PROFILES
1. 12.1 Bracco Imaging
  1. 12.1.1 Financial Overview
  2. 12.1.2 Products Offered
  3. 12.1.3 Key Developments
  4. 12.1.4 SWOT Analysis
  5. 12.1.5 Key Strategies
2. 12.2 Novartis
  1. 12.2.1 Financial Overview
  2. 12.2.2 Products Offered
  3. 12.2.3 Key Developments
  4. 12.2.4 SWOT Analysis
  5. 12.2.5 Key Strategies
3. 12.3 Bayer
  1. 12.3.1 Financial Overview
  2. 12.3.2 Products Offered
  3. 12.3.3 Key Developments
  4. 12.3.4 SWOT Analysis
  5. 12.3.5 Key Strategies
4. 12.4 General Electric
  1. 12.4.1 Financial Overview
  2. 12.4.2 Products Offered
  3. 12.4.3 Key Developments
  4. 12.4.4 SWOT Analysis
  5. 12.4.5 Key Strategies
5. 12.5 Draximage
  1. 12.5.1 Financial Overview
  2. 12.5.2 Products Offered
  3. 12.5.3 Key Developments
  4. 12.5.4 SWOT Analysis
  5. 12.5.5 Key Strategies
6. 12.6 Actinium Pharmaceuticals
  1. 12.6.1 Financial Overview
  2. 12.6.2 Products Offered
  3. 12.6.3 Key Developments
  4. 12.6.4 SWOT Analysis
  5. 12.6.5 Key Strategies
7. 12.7 Lantheus Medical Imaging
  1. 12.7.1 Financial Overview
  2. 12.7.2 Products Offered
  3. 12.7.3 Key Developments
  4. 12.7.4 SWOT Analysis
  5. 12.7.5 Key Strategies
8. 12.8 Siemens Healthineers
  1. 12.8.1 Financial Overview
  2. 12.8.2 Products Offered
  3. 12.8.3 Key Developments
  4. 12.8.4 SWOT Analysis
  5. 12.8.5 Key Strategies
9. 12.9 Elekta
  1. 12.9.1 Financial Overview
  2. 12.9.2 Products Offered
  3. 12.9.3 Key Developments
  4. 12.9.4 SWOT Analysis
  5. 12.9.5 Key Strategies
10. 12.10 NorthStar Medical Radioisotopes
  1. 12.10.1 Financial Overview
  2. 12.10.2 Products Offered
  3. 12.10.3 Key Developments
  4. 12.10.4 SWOT Analysis
  5. 12.10.5 Key Strategies
11. 12.11 Ion Beam Applications
  1. 12.11.1 Financial Overview
  2. 12.11.2 Products Offered
  3. 12.11.3 Key Developments
  4. 12.11.4 SWOT Analysis
  5. 12.11.5 Key Strategies
12. 12.12 Cardinal Health
  1. 12.12.1 Financial Overview
  2. 12.12.2 Products Offered
  3. 12.12.3 Key Developments
  4. 12.12.4 SWOT Analysis
  5. 12.12.5 Key Strategies
13. 12.13 TheraSource
  1. 12.13.1 Financial Overview
  2. 12.13.2 Products Offered
  3. 12.13.3 Key Developments
  4. 12.13.4 SWOT Analysis
  5. 12.13.5 Key Strategies
14. 12.14 BristolMyers Squibb
  1. 12.14.1 Financial Overview
  2. 12.14.2 Products Offered
  3. 12.14.3 Key Developments
  4. 12.14.4 SWOT Analysis
  5. 12.14.5 Key Strategies
15. 12.15 AbbVie
  1. 12.15.1 Financial Overview
  2. 12.15.2 Products Offered
  3. 12.15.3 Key Developments
  4. 12.15.4 SWOT Analysis
  5. 12.15.5 Key Strategies
13 APPENDIX
1. 13.1 References
2. 13.2 Related Reports
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 3 NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 4 NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 5 NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 6 NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7 US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 8 US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 9 US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 10 US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 11 US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12 CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 13 CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 14 CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 15 CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 16 CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17 EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 18 EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 19 EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 20 EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 21 EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22 GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 23 GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 24 GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 25 GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 26 GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27 UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 28 UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 29 UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 30 UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 31 UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32 FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 33 FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 34 FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 35 FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 36 FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37 RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 38 RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 39 RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 40 RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 41 RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42 ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 43 ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 44 ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 45 ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 46 ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47 SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 48 SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 49 SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 50 SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 51 SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52 REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 53 REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 54 REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 55 REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 56 REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57 APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 58 APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 59 APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 60 APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 61 APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62 CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 63 CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 64 CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 65 CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 66 CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67 INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 68 INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 69 INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 70 INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 71 INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72 JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 73 JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 74 JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 75 JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 76 JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77 SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 78 SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 79 SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 80 SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 81 SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82 MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 83 MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 84 MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 85 MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 86 MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87 THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 88 THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 89 THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 90 THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 91 THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92 INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 93 INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 94 INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 95 INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 96 INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97 REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 98 REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 99 REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 100 REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 101 REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 103 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 104 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 105 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 106 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107 BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 108 BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 109 BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 110 BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 111 BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112 MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 113 MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 114 MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 115 MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 116 MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117 ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 118 ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 119 ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 120 ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 121 ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 123 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 124 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 125 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 126 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127 MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 128 MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 129 MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 130 MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 131 MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 133 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 134 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 135 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 136 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 138 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 139 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 140 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 141 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142 REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 143 REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 144 REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 145 REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 146 REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148 ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 NORTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 3 US RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 4 US RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 5 US RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 6 US RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 7 US RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 8 CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 9 CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 10 CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 11 CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 12 CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 13 EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 14 GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 15 GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 16 GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 17 GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 18 GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 19 UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 20 UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 21 UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 22 UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 23 UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 24 FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 25 FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 26 FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 27 FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 28 FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 29 RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 30 RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 31 RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 32 RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 33 RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 34 ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 35 ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 36 ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 37 ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 38 ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 39 SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 40 SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 41 SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 42 SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 43 SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 44 REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 45 REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 46 REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 47 REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 48 REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 49 APAC RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 50 CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 51 CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 52 CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 53 CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 54 CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 55 INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 56 INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 57 INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 58 INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 59 INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 60 JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 61 JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 62 JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 63 JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 64 JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 65 SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 66 SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 67 SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 68 SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 69 SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 70 MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 71 MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 72 MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 73 MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 74 MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 75 THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 76 THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 77 THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 78 THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 79 THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 80 INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 81 INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 82 INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 83 INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 84 INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 85 REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 86 REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 87 REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 88 REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 89 REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 90 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 91 BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 92 BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 93 BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 94 BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 95 BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 96 MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 97 MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 98 MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 99 MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 100 MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 101 ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 102 ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 103 ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 104 ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 105 ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 106 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 107 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 108 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 109 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 110 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 111 MEA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 112 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 113 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 114 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 115 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 116 GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 117 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 118 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 119 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 120 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 121 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 122 REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 123 REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 124 REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 125 REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 126 REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 127 KEY BUYING CRITERIA OF RADIOPHARMACEUTICALS MARKET
FIGURE 128 RESEARCH PROCESS OF MRFR
FIGURE 129 DRO ANALYSIS OF RADIOPHARMACEUTICALS MARKET
FIGURE 130 DRIVERS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET
FIGURE 131 RESTRAINTS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET
FIGURE 132 SUPPLY / VALUE CHAIN: RADIOPHARMACEUTICALS MARKET
FIGURE 133 RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2025 (% SHARE)
FIGURE 134 RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
FIGURE 135 RADIOPHARMACEUTICALS MARKET, BY TYPE, 2025 (% SHARE)
FIGURE 136 RADIOPHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
FIGURE 137 RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2025 (% SHARE)
FIGURE 138 RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2019 TO 2035 (USD Billions)
FIGURE 139 RADIOPHARMACEUTICALS MARKET, BY END USE, 2025 (% SHARE)
FIGURE 140 RADIOPHARMACEUTICALS MARKET, BY END USE, 2019 TO 2035 (USD Billions)
FIGURE 141 RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142 RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143 BENCHMARKING OF MAJOR COMPETITORS
1. "

Segmentation du marché des radiopharmaceutiques

Marché des radiopharmaceutiques par application (milliards USD, 2019-2035)
- Diagnostic
- Thérapie
- Recherche
Marché des radiopharmaceutiques par type (milliards USD, 2019-2035)
- Radiopharmaceutiques diagnostiques
- Radiopharmaceutiques thérapeutiques
Marché des radiopharmaceutiques par classe de radiopharmaceutiques (milliards USD, 2019-2035)
- Radioisotopes
- Composés radiomarqués
- Générateurs de radiopharmaceutiques
Marché des radiopharmaceutiques par utilisation finale (milliards USD, 2019-2035)
- Hôpitaux
- Centres d'imagerie diagnostique
- Institutions de recherche
Marché des radiopharmaceutiques par région (milliards USD, 2019-2035)
- Amérique du Nord
- Europe
- Amérique du Sud
- Asie-Pacifique
- Moyen-Orient et Afrique

Perspectives régionales du marché des radiopharmaceutiques (milliards USD, 2019-2035)

Perspectives de l'Amérique du Nord (milliards USD, 2019-2035)
- Marché des radiopharmaceutiques en Amérique du Nord par type d'application
  - Diagnostic
  - Thérapie
  - Recherche
- Marché des radiopharmaceutiques en Amérique du Nord par type
  - Radiopharmaceutiques diagnostiques
  - Radiopharmaceutiques thérapeutiques
- Marché des radiopharmaceutiques en Amérique du Nord par type de classe de radiopharmaceutiques
  - Radioisotopes
  - Composés radiomarqués
  - Générateurs de radiopharmaceutiques
- Marché des radiopharmaceutiques en Amérique du Nord par type d'utilisation finale
  - Hôpitaux
  - Centres d'imagerie diagnostique
  - Institutions de recherche
- Marché des radiopharmaceutiques en Amérique du Nord par type régional
  - États-Unis
  - Canada
- Perspectives des États-Unis (milliards USD, 2019-2035)
- Marché des radiopharmaceutiques aux États-Unis par type d'application
  - Diagnostic
  - Thérapie
  - Recherche
- Marché des radiopharmaceutiques aux États-Unis par type
  - Radiopharmaceutiques diagnostiques
  - Radiopharmaceutiques thérapeutiques
- Marché des radiopharmaceutiques aux États-Unis par type de classe de radiopharmaceutiques
  - Radioisotopes
  - Composés radiomarqués
  - Générateurs de radiopharmaceutiques
- Marché des radiopharmaceutiques aux États-Unis par type d'utilisation finale
  - Hôpitaux
  - Centres d'imagerie diagnostique
  - Institutions de recherche
- Perspectives du Canada (milliards USD, 2019-2035)
- Marché des radiopharmaceutiques au Canada par type d'application
  - Diagnostic
  - Thérapie
  - Recherche
- Marché des radiopharmaceutiques au Canada par type
  - Radiopharmaceutiques diagnostiques
  - Radiopharmaceutiques thérapeutiques
- Marché des radiopharmaceutiques au Canada par type de classe de radiopharmaceutiques
  - Radioisotopes
  - Composés radiomarqués
  - Générateurs de radiopharmaceutiques
- Marché des radiopharmaceutiques au Canada par type d'utilisation finale
  - Hôpitaux
  - Centres d'imagerie diagnostique
  - Institutions de recherche
- Perspectives de l'Europe (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en Europe par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en Europe par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en Europe par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en Europe par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Marché des radiopharmaceutiques en Europe par type régional
    - Allemagne
    - Royaume-Uni
    - France
    - Russie
    - Italie
    - Espagne
    - Reste de l'Europe
  - Perspectives de l'Allemagne (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en Allemagne par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en Allemagne par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en Allemagne par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en Allemagne par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives du Royaume-Uni (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques au Royaume-Uni par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques au Royaume-Uni par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques au Royaume-Uni par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques au Royaume-Uni par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives de la France (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en France par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en France par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en France par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en France par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives de la Russie (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en Russie par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en Russie par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en Russie par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en Russie par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives de l'Italie (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en Italie par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en Italie par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en Italie par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en Italie par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives de l'Espagne (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques en Espagne par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques en Espagne par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques en Espagne par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques en Espagne par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives du reste de l'Europe (milliards USD, 2019-2035)
  - Marché des radiopharmaceutiques dans le reste de l'Europe par type d'application
    - Diagnostic
    - Thérapie
    - Recherche
  - Marché des radiopharmaceutiques dans le reste de l'Europe par type
    - Radiopharmaceutiques diagnostiques
    - Radiopharmaceutiques thérapeutiques
  - Marché des radiopharmaceutiques dans le reste de l'Europe par type de classe de radiopharmaceutiques
    - Radioisotopes
    - Composés radiomarqués
    - Générateurs de radiopharmaceutiques
  - Marché des radiopharmaceutiques dans le reste de l'Europe par type d'utilisation finale
    - Hôpitaux
    - Centres d'imagerie diagnostique
    - Institutions de recherche
  - Perspectives de l'APAC (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en APAC par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en APAC par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en APAC par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en APAC par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Marché des radiopharmaceutiques en APAC par type régional
      - Chine
      - Inde
      - Japon
      - Corée du Sud
      - Malaisie
      - Thaïlande
      - Indonésie
      - Reste de l'APAC
    - Perspectives de la Chine (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Chine par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Chine par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Chine par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Chine par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de l'Inde (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Inde par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Inde par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Inde par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Inde par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives du Japon (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques au Japon par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques au Japon par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques au Japon par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques au Japon par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de la Corée du Sud (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Corée du Sud par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Corée du Sud par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Corée du Sud par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Corée du Sud par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de la Malaisie (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Malaisie par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Malaisie par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Malaisie par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Malaisie par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de la Thaïlande (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Thaïlande par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Thaïlande par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Thaïlande par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Thaïlande par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de l'Indonésie (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques en Indonésie par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques en Indonésie par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques en Indonésie par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques en Indonésie par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives du reste de l'APAC (milliards USD, 2019-2035)
    - Marché des radiopharmaceutiques dans le reste de l'APAC par type d'application
      - Diagnostic
      - Thérapie
      - Recherche
    - Marché des radiopharmaceutiques dans le reste de l'APAC par type
      - Radiopharmaceutiques diagnostiques
      - Radiopharmaceutiques thérapeutiques
    - Marché des radiopharmaceutiques dans le reste de l'APAC par type de classe de radiopharmaceutiques
      - Radioisotopes
      - Composés radiomarqués
      - Générateurs de radiopharmaceutiques
    - Marché des radiopharmaceutiques dans le reste de l'APAC par type d'utilisation finale
      - Hôpitaux
      - Centres d'imagerie diagnostique
      - Institutions de recherche
    - Perspectives de l'Amérique du Sud (milliards USD, 2019-2035)
      - Marché des radiopharmaceutiques en Amérique du Sud par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
      - Marché des radiopharmaceutiques en Amérique du Sud par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
      - Marché des radiopharmaceutiques en Amérique du Sud par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
      - Marché des radiopharmaceutiques en Amérique du Sud par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
      - Marché des radiopharmaceutiques en Amérique du Sud par type régional
        
        Brésil
        
        Mexique
        
        Argentine
        
        Reste de l'Amérique du Sud
      - Perspectives du Brésil (milliards USD, 2019-2035)
      - Marché des radiopharmaceutiques au Brésil par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
      - Marché des radiopharmaceutiques au Brésil par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
      - Marché des radiopharmaceutiques au Brésil par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
      - Marché des radiopharmaceutiques au Brésil par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
      - Perspectives du Mexique (milliards USD, 2019-2035)
      - Marché des radiopharmaceutiques au Mexique par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
      - Marché des radiopharmaceutiques au Mexique par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
      - Marché des radiopharmaceutiques au Mexique par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
      - Marché des radiopharmaceutiques au Mexique par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
      - Perspectives de l'Argentine (milliards USD, 2019-2035)
      - Marché des radiopharmaceutiques en Argentine par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
      - Marché des radiopharmaceutiques en Argentine par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
      - Marché des radiopharmaceutiques en Argentine par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
      - Marché des radiopharmaceutiques en Argentine par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
      - Perspectives du reste de l'Amérique du Sud (milliards USD, 2019-2035)
      - Marché des radiopharmaceutiques dans le reste de l'Amérique du Sud par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
      - Marché des radiopharmaceutiques dans le reste de l'Amérique du Sud par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
      - Marché des radiopharmaceutiques dans le reste de l'Amérique du Sud par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
      - Marché des radiopharmaceutiques dans le reste de l'Amérique du Sud par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
      - Perspectives de la MEA (milliards USD, 2019-2035)
        
        Marché des radiopharmaceutiques dans la MEA par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
        
        Marché des radiopharmaceutiques dans la MEA par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
        
        Marché des radiopharmaceutiques dans la MEA par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
        
        Marché des radiopharmaceutiques dans la MEA par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
        
        Marché des radiopharmaceutiques dans la MEA par type régional
        
        Pays du CCG
        
        Afrique du Sud
        
        Reste de la MEA
        
        Perspectives des pays du CCG (milliards USD, 2019-2035)
        
        Marché des radiopharmaceutiques dans les pays du CCG par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
        
        Marché des radiopharmaceutiques dans les pays du CCG par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
        
        Marché des radiopharmaceutiques dans les pays du CCG par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
        
        Marché des radiopharmaceutiques dans les pays du CCG par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
        
        Perspectives de l'Afrique du Sud (milliards USD, 2019-2035)
        
        Marché des radiopharmaceutiques en Afrique du Sud par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
        
        Marché des radiopharmaceutiques en Afrique du Sud par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
        
        Marché des radiopharmaceutiques en Afrique du Sud par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
        
        Marché des radiopharmaceutiques en Afrique du Sud par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche
        
        Perspectives du reste de la MEA (milliards USD, 2019-2035)
        
        Marché des radiopharmaceutiques dans le reste de la MEA par type d'application
        
        Diagnostic
        
        Thérapie
        
        Recherche
        
        Marché des radiopharmaceutiques dans le reste de la MEA par type
        
        Radiopharmaceutiques diagnostiques
        
        Radiopharmaceutiques thérapeutiques
        
        Marché des radiopharmaceutiques dans le reste de la MEA par type de classe de radiopharmaceutiques
        
        Radioisotopes
        
        Composés radiomarqués
        
        Générateurs de radiopharmaceutiques
        
        Marché des radiopharmaceutiques dans le reste de la MEA par type d'utilisation finale
        
        Hôpitaux
        
        Centres d'imagerie diagnostique
        
        Institutions de recherche

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Étude de cas

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

Marché des radio-pharmaceutiques

Rapports connexes

Customer Stories

Aerospace & Defense

Compare Licence